thereby reducing endothelial dysfunction and atherosclerosis
It mediates the polymerization of both IgM and IgA immunoglobulins
with C-His tag) VPEPKPSTLYPWRRASAPGRVRRAWVIPPISVSENHKRLPYPLVQIKSDKQQLGSVIYSIQGPGVDEEPRNVFSIDKFTGRVYLNATLDREKTDRFRLRAFALDLGGSTLEDPTDLEIVVVDQNDNRPAFLQDVFRGRILEGAIPGTFVTRAEATDADDPETDNAALRFSILEQGSPEFFSIDEHTGEIRTVQVGLDREVVAVYNLTLQVADMSGDGLTATASAIISIDDINDNAPEFTKDEFFMEAAEAVSGVDVGRLEVEDKDLPGSPNWVARFTILEGDPDGQFKIYTDPKTNEGVLSVVKPLDYESREQYELRVSVQNEAPLQAAAPRARRGQTRVSVWVQDTNEAPVFPENPLRTSIAEGAPPGTSVATFSARDPDTEQLQRISYSKDYDPEDWLQVDGATGRIQTQRVLSPASPFLKDGWYRAIILALDNAIPPSTATGTLSIEILEVNDHAPALALPPSGSLCSEPDQGPGLLLGATDEDLPPHGAPFHFQLNPRVPDLGRNWSVSQINVSHARLRLRHQVSEGLHRLSLLLQDSGEPPQQREQTLNVTVCRCGSDGTCLPGAAALRGGGVGVSLGA
By binding to n-3 and n-9 polyunsaturated fatty acids (PUFAs)
C5AR1 Immunogen Synthetic Peptide Location Cell membrane Accession P21730 Clone Number S-1921-43 Antibody Type Recombinant mAb Isotype IgG Application IHC-P
AXL Recombinant Rabbit mAb (S-2199-80) WB thereby reducing endothelial dysfunction andProduct Specification Host Rabbit Antigen AXL Synonyms Tyrosine protein kinase receptor UFO; AXL oncogene; UFO Immunogen Recombinant Protein Location Cell membrane Accession P30530 Clone Number S 2199 80 Antibody Type Recombinant mAb Isotype IgG Application WB, IHC P, ICC Reactivity Hu Positive Sample HeLa, HUVEC, COS 7 Purification Protein A Concentration 0. 5 mg ml Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS, 40% Glycerol,